Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Benign Hematology
•
Hospital Medicine
Would you start a patient with sickle cell disease and COVID-19 on prophylactic anticoagulation?
Related Questions
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Is there any indication for hydroxyurea in patients with sickle cell trait?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
